Effectiveness of a Program to Slow the Progression of Chronic Kidney Disease
- Conditions
- T2DM Patients with HT and CKD 3 complicationRISK FACTORS MODIFICATION/ SLOW PROGRESSION OF KIDNEY DISEASECKD STAGE 3THE INFORMATION MOTIVATION BEHAVIORAL SKILLS MODEL
- Registration Number
- TCTR20230830001
- Lead Sponsor
- Praboromarajchanok Institute, Thailand.
- Brief Summary
The results showed that after the experiment, the experimental group had significantly higher mean scores in terms of knowledge, perceived benefits, perceived severity, self-efficacy, and behaviors to slow the progression of kidney disease than the control group . Further, the experimental group had significantly better clinical outcomes (SBP, DBP, eGFR, BUN, creatinine, albuminuria, FBS, and HbA1c) than the control group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 76
1. patients with diabetes and hypertension with CKD 3 complication
2. aged 40 to70 years,
3. blood pressure > 140/90 mmHg at least once in the last six months
4. HbA1C > 7% in the last six months
5. able to communicate, read, and write in Thai
6. lived with their family
7. no complications or severe illnesses during the study that might have caused any obstacle to activity participation.
1.Need to be relocated away from Samutprakarn province during the study.
2.Request to be withdrawn from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method knowledge, perceived disease severity, perceived benefits of disease slow progression, self-efficacy, and behavioral to slow the progression of kidney disease Pre-experimental , week 10, and week 14 questionnaire
- Secondary Outcome Measures
Name Time Method Clinical outcomes (kidney function (eGFR, BUN, Cr, albuminuria), blood sugar (FBS and HbA1C), nutrition stage (BMI), and blood pressure (SBP and DBP).) Pre-experimental and week 14 Laboratory test